Mabion S.A. (MAB) - Net Assets

Latest as of September 2025: zł70.02 Million PLN ≈ $19.27 Million USD

Based on the latest financial reports, Mabion S.A. (MAB) has net assets worth zł70.02 Million PLN (≈ $19.27 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł120.46 Million ≈ $33.15 Million USD) and total liabilities (zł50.44 Million ≈ $13.88 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Mabion S.A. (MAB) asset resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	zł70.02 Million
% of Total Assets	58.13%
Annual Growth Rate	N/A
5-Year Change	N/A
10-Year Change	-12.69%
Growth Volatility	2635.16

Mabion S.A. - Net Assets Trend (2009–2024)

This chart illustrates how Mabion S.A.'s net assets have evolved over time, based on quarterly financial data. Also explore Mabion S.A. balance sheet assets for the complete picture of this company's asset base.

Annual Net Assets for Mabion S.A. (2009–2024)

The table below shows the annual net assets of Mabion S.A. from 2009 to 2024. For live valuation and market cap data, see MAB market cap overview.

Year	Net Assets	Change
2024-12-31	zł111.44 Million ≈ $30.67 Million	-5.38%
2023-12-31	zł117.78 Million ≈ $32.41 Million	+53.94%
2022-12-31	zł76.51 Million ≈ $21.06 Million	+43.51%
2021-12-31	zł53.31 Million ≈ $14.67 Million	+168.89%
2020-12-31	zł-77.39 Million ≈ $-21.30 Million	-258.61%
2019-12-31	zł-21.58 Million ≈ $-5.94 Million	-151.21%
2018-12-31	zł42.14 Million ≈ $11.60 Million	+177.81%
2017-12-31	zł-54.16 Million ≈ $-14.91 Million	-1552.35%
2016-12-31	zł3.73 Million ≈ $1.03 Million	-97.08%
2015-12-31	zł127.64 Million ≈ $35.13 Million	-87.21%
2014-12-31	zł997.84 Million ≈ $274.62 Million	+91.69%
2013-12-31	zł520.55 Million ≈ $143.26 Million	-71.47%
2012-12-31	zł1.82 Billion ≈ $502.09 Million	+8858.29%
2011-12-31	zł20.37 Million ≈ $5.60 Million	-6.23%
2010-12-31	zł21.72 Million ≈ $5.98 Million	+29137.19%
2009-12-31	zł-74.80K ≈ $-20.59K	--

Equity Component Analysis

This analysis shows how different components contribute to Mabion S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 15023420202.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	zł1.62 Million	1.45%
Other Comprehensive Income	zł23.19 Million	20.81%
Other Components	zł237.44 Million	213.06%
Total Equity	zł111.44 Million	100.00%

Mabion S.A. Competitors by Market Cap

The table below lists competitors of Mabion S.A. ranked by their market capitalization.

Company	Market Cap
Creative Realities Inc NASDAQ:CREX	$33.24 Million
Chiu Ting Machinery Co Ltd TW:1539	$33.26 Million
Yoo Sung Ent KO:002920	$33.27 Million
Kim Hin Industry Bhd KLSE:5371	$33.27 Million
Wayi International Digital Entertainment Co TWO:3086	$33.16 Million
Theradiag SA PA:ALTHE	$33.15 Million
Symphony Life Bhd KLSE:1538	$33.15 Million
TPC CONSOLIDATED LTD. F:T7P	$33.15 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Mabion S.A.'s equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 117,776,000 to 111,442,000, a change of -6,334,000 (-5.4%).
Net loss of 6,334,000 reduced equity.
Other comprehensive income increased equity by 1,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	zł-6.33 Million	-5.68%
Other Comprehensive Income	zł1.00K	+0.0%
Other Changes	zł-1.00K	-0.0%
Total Change	zł-	-5.38%

Book Value vs Market Value Analysis

This analysis compares Mabion S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.08x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2009-12-31	zł-0.01	zł7.47	x
2010-12-31	zł3.15	zł7.47	x
2011-12-31	zł4.17	zł7.47	x
2012-12-31	zł342.28	zł7.47	x
2013-12-31	zł65.64	zł7.47	x
2014-12-31	zł99.20	zł7.47	x
2015-12-31	zł11.73	zł7.47	x
2016-12-31	zł0.32	zł7.47	x
2017-12-31	zł-4.59	zł7.47	x
2018-12-31	zł3.22	zł7.47	x
2019-12-31	zł-1.57	zł7.47	x
2020-12-31	zł-5.64	zł7.47	x
2021-12-31	zł3.43	zł7.47	x
2022-12-31	zł4.73	zł7.47	x
2023-12-31	zł7.29	zł7.47	x
2024-12-31	zł6.90	zł7.47	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Mabion S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -5.68%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -9.18%
• Asset Turnover: 0.43x
• Equity Multiplier: 1.43x
Recent ROE (-5.68%) is above the historical average (-100.42%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2009	0.00%	0.00%	0.00x	0.00x	zł-321.27K
2010	2.17%	30.86%	0.07x	1.08x	zł-1.70 Million
2011	-6.65%	-137.41%	0.04x	1.32x	zł-3.39 Million
2012	-0.12%	-239.77%	0.00x	2.17x	zł-184.56 Million
2013	-0.75%	-67089.66%	0.00x	1.45x	zł-55.95 Million
2014	-0.45%	-537.69%	0.00x	1.48x	zł-104.25 Million
2015	-3.60%	-168.20%	0.01x	1.52x	zł-17.36 Million
2016	-1497.08%	0.00%	0.00x	24.47x	zł-56.20 Million
2017	0.00%	0.00%	0.00x	0.00x	zł-52.47 Million
2018	-163.44%	0.00%	0.00x	3.43x	zł-73.08 Million
2019	0.00%	0.00%	0.00x	0.00x	zł-62.55 Million
2020	0.00%	-3596.73%	0.02x	0.00x	zł-49.45 Million
2021	3.57%	3.35%	0.31x	3.46x	zł-3.43 Million
2022	30.31%	14.14%	0.88x	2.43x	zł15.54 Million
2023	35.04%	27.21%	0.73x	1.77x	zł29.49 Million
2024	-5.68%	-9.18%	0.43x	1.43x	zł-17.48 Million

Industry Comparison

This section compares Mabion S.A.'s net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $118,837,845
Average return on equity (ROE) among peers: -34.85%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Mabion S.A. (MAB)	zł70.02 Million	0.00%	0.72x	$33.23 Million
Bioton S.A. (BIO)	$808.11 Million	11.47%	0.23x	$98.54 Million
Captor Therapeutics S.A. (CTX)	$3.43 Million	-128.88%	4.26x	$119.47 Million
Molecure S.A. (MOC)	$126.45 Million	-10.71%	0.09x	$31.98 Million
Nanogroup SA (NNG)	$-252.70K	0.00%	0.00x	$22.04 Million
Pharmena S.A. (PHR)	$-348.00K	0.00%	0.00x	$10.02 Million
PolTREG S.A. (PTG)	$87.52 Million	-15.48%	0.45x	$21.82 Million
Pure Biologics Spólka Akcyjna (PUR)	$311.70K	-138.89%	2.05x	$7.58 Million
Ryvu Therapeutics SA (RVU)	$11.46 Million	-38.73%	0.53x	$152.71 Million
Synthaverse S.A. (SVE)	$32.87 Million	7.55%	1.47x	$68.82 Million

About Mabion S.A.

WAR:MAB Poland Biotechnology

Market Cap

$33.23 Million

zł120.73 Million PLN

Market Cap Rank

#23379 Global

#216 in Poland

Share Price

zł7.47

Change (1 day)

+3.75%

52-Week Range

zł6.82 - zł10.64

All Time High

zł134.60